Podcast
Questions and Answers
What is the primary mechanism of action of SGLT2 inhibitors?
What is the primary mechanism of action of SGLT2 inhibitors?
- Decreasing the rate of gastric emptying to slow glucose absorption
- Increasing insulin secretion to lower blood glucose levels
- Inhibiting the SGLT2 receptors in the proximal tubule to prevent glucose reabsorption (correct)
- Increasing glucagon secretion to raise blood glucose levels
What is the typical reduction in HbA1c observed with SGLT2 inhibitor therapy?
What is the typical reduction in HbA1c observed with SGLT2 inhibitor therapy?
- 0.7-1.1% (correct)
- 0.8-1.9%
- No significant reduction in HbA1c
- 2-3%
Which of the following is a common adverse effect associated with SGLT2 inhibitor use?
Which of the following is a common adverse effect associated with SGLT2 inhibitor use?
- Genitourinary infections (correct)
- Liver toxicity
- Decreased HDL cholesterol
- Hypoglycemia
How do SGLT2 inhibitors compare to incretin mimetics in terms of their mechanism of action?
How do SGLT2 inhibitors compare to incretin mimetics in terms of their mechanism of action?
Which of the following is a known cardiovascular benefit associated with SGLT2 inhibitor use?
Which of the following is a known cardiovascular benefit associated with SGLT2 inhibitor use?
What is a potential disadvantage of SGLT2 inhibitor therapy?
What is a potential disadvantage of SGLT2 inhibitor therapy?
What is the typical weight loss observed with SGLT2 inhibitor therapy?
What is the typical weight loss observed with SGLT2 inhibitor therapy?
Which of the following is a common comorbidity associated with diabetes?
Which of the following is a common comorbidity associated with diabetes?
What is the leading cause of hospitalization in patients with diabetes?
What is the leading cause of hospitalization in patients with diabetes?
Which of the following is a potential disadvantage of using SGLT2 inhibitors for the management of diabetes?
Which of the following is a potential disadvantage of using SGLT2 inhibitors for the management of diabetes?
How do SGLT2 inhibitors compare to incretin mimetics in terms of their mechanism of action?
How do SGLT2 inhibitors compare to incretin mimetics in terms of their mechanism of action?
What is the primary mechanism of action of SGLT2 inhibitors in the management of diabetes?
What is the primary mechanism of action of SGLT2 inhibitors in the management of diabetes?
Which of the following is a known cardiovascular benefit associated with the use of SGLT2 inhibitors?
Which of the following is a known cardiovascular benefit associated with the use of SGLT2 inhibitors?
Which of the following is a common comorbidity associated with diabetes?
Which of the following is a common comorbidity associated with diabetes?
What is the typical weight loss observed with SGLT2 inhibitor therapy in patients with diabetes?
What is the typical weight loss observed with SGLT2 inhibitor therapy in patients with diabetes?
What is the leading cause of hospitalization in patients with diabetes?
What is the leading cause of hospitalization in patients with diabetes?
Which of the following is a common adverse effect associated with the use of SGLT2 inhibitors?
Which of the following is a common adverse effect associated with the use of SGLT2 inhibitors?
What is the typical reduction in HbA1c observed with SGLT2 inhibitor therapy in patients with diabetes?
What is the typical reduction in HbA1c observed with SGLT2 inhibitor therapy in patients with diabetes?
Flashcards are hidden until you start studying
